期刊文献+

一种苯并咪唑酮类GSK-3抑制剂的纯度研究

Study on purity of GSK-3 inhibitor benzimidazolone
下载PDF
导出
摘要 目的:建立苯并咪唑酮类新型GSK-3抑制剂的纯度测定方法。方法:采用高效液相色谱法,采用Phenomenex Gemini C_(18)110A色谱柱(4.6 mm×250 mm,5μm),甲醇-水(75∶25)为流动相,流速1 m L﹒min^(-1),柱温为30℃,检测波长254 nm。结果:苯并咪唑酮类GSK-3抑制剂(化合物5b)的含量在20~100μg﹒mL^(-1)的浓度范围内与峰面积具有良好的线性关系(r=0.9999),平均加样回收率为100.44%,RSD为0.78%。结论:该纯度测定方法简便高效、实用可靠,可用于指导苯并咪唑酮类新型GSK-3抑制剂的合成及系列衍生物的纯度测定。 Objective: To establish a new method for the purity determination of benzimidazolone derivatives of GSK-3 inhibitor. Method: The determination was performed on a Phenomenex Gemini C18 110 A column(4.6 mm × 250 mm, 5 μm) with PDA detector at 254 nm with methanol-water(75∶25) as the mobile phase. The flow rate was 1 mL﹒min^-1 and the column temperature was 30℃. Result: The content of GSK-3 inhibitor(compound 5 b) showed a good linear relationship with the peak area in the concentration range of 20100 μg﹒mL^-1(r=0.9999). The average recovery rate and the relative standard deviation of compound 5 b were 100.44% and 0.78%, respectively. Conclusion: The method is simple and efficient,practical and reliable, which can be used to guide the synthesis of benzimidazolones, a novel GSK-3 inhibitor, and the purity determination of series of derivatives.
作者 陈换飞 邹静 白兰 贾贵清 彭婷 陈婷 吴小愚 张梅 CHEN Huan-fei;ZOU Jing;BAI Lan;JIA Gui-qing;PENG Ting;CHEN Ting;WU Xiao-yu;ZHANG Mei(School of Pharmacy,Chengdu University of Traditional Chinese Medicine,Key Laboratory of Standardization far Chinese Herbal Medicine,Ministry of Education,National Key Laboratory Breeding Base of Systematic Research,Development and Utilization of Chinese Medicine Resources,Chengdu 611137,Sichuan;Sichuan Provincial Academy of Medical Sciences&Sichuan Provincial People's Hospital,Department of Pharmacy,Personalized Drug Therapy Key Laboratory of Sichuan Province,Chengdu 610072,Sichuan;Sichuan Cologne Pharmaceutical Co.,Ltd,.Chengdu 610071,Sichuan)
出处 《中药与临床》 2018年第2期32-35,共4页 Pharmacy and Clinics of Chinese Materia Medica
基金 四川省卫计委课题16PJ481 四川省医学科学院.四川省人民医院青年基金2015QN11 国家临床药学重点专科建设项目NO.30305030698
关键词 GSK-3抑制剂 苯并咪唑酮衍生物 高效液相色谱法 纯度测定 GSK-3 inhibitor benzimidazolone derivatives HPLC purity determination
  • 相关文献

参考文献2

二级参考文献94

  • 1谌喜珠 刘伟平 何键.分析试验室,2003,22:207-209.
  • 2FrameS, Cohen P, Biondi R M. Mol. Cell, 2001, 7: 1321-1327.
  • 3Rothenberg M, Carbone D, Johnson D. Nat. Rev. Cancer,2003, 3:303-309.
  • 4Ali A, Hoeflich K P, Woodgett J R. Chem. Rev., 2001, 101 :2527-2540.
  • 5Grimes C A, Jope R S. Prog. Neurobiol., 2001, 65:391-426.
  • 6Eldar-Finkelman H. Trends. Mol. Med., 2002, 8:126-132.
  • 7Castro A, Martinez A. Exp. Opin. Ther. Pat., 2000, 10:1519-1527.
  • 8Kim L, Kimmel A R. Curr. Opin. Genet. Dev., 2000, 10:508-514.
  • 9Wag-man A S, Nuss J M. Curr. Pharm. Design., 2001, 7:417 -450.
  • 10Hoeflich K P, Luo J, Rubie E A, et al. Nature, 2000, 406:86-90.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部